Telomerase inhibition is being explored as a potential cancer treatment. Telomeres protect the ends of chromosomes but shorten with each cell division, eventually causing genomic instability and cell death if they become too short. Cancer cells reactivate telomerase to maintain telomere length and immortality. Scientists hope to use telomerase inhibition to selectively target cancer cells. Research has also shown that modifying stem cells with the PIM-1 protein can rejuvenate aging heart cells by extending telomere length, offering potential regenerative therapies for heart disease. Advances in genetic research may allow for earlier disease detection and prevention.